Text Size

Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology

This study is currently recruiting participants.
Verified December 2011 by King Faisal Specialist Hospital & Research Center
Sponsor:
Information provided by (Responsible Party):
King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier:
NCT01310946
First received: March 6, 2011
Last updated: December 11, 2011
Last verified: December 2011
History of Changes
  Purpose

Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology


Condition Intervention
Acute Lymphocytic Leukemia
 Other: Database

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by King Faisal Specialist Hospital & Research Center:

Estimated Enrollment: 203
Study Start Date: June 2003
Intervention Details:
    Other: Database
    Database
    Other Name: Database
Detailed Description:

Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology

  Eligibility

Ages Eligible for Study:   14 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Acute Lymphocytic Leukemia Database

Criteria

Inclusion Criteria:

  • Patients with diagnosed Acute Lymphocytic Leukemia

Exclusion Criteria:

  • Patients with diagnosis other than Acute Lymphocytic Leukemia
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01310946

Contacts
Contact: N Chaudhri, M.D. +966-1-4423949

Locations
Saudi Arabia
Kfsh & Rc Recruiting
Riyadh, Saudi Arabia
Sponsors and Collaborators
King Faisal Specialist Hospital & Research Center
Investigators
Principal Investigator: N Chaudhri, M.D. KFSH & RC
  More Information

No publications provided

Responsible Party: King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier: NCT01310946     History of Changes
Other Study ID Numbers: RAC# 2021-051, RAC# 2021-051
Study First Received: March 6, 2011
Last Updated: December 11, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by King Faisal Specialist Hospital & Research Center:
Acute Lymphocytic Leukemia

Additional relevant MeSH terms:
Leukemia
Leukemia, Lymphoid
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Neoplasms by Histologic Type
Neoplasms
 Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases

ClinicalTrials.gov processed this record on June 13, 2013